A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocol.
Patrik NasrMikael Fredrik ForsgrenWile BalkhedCecilia JönssonNils DahlströmChristian SimonssonShan CaiAnna CederborgMartin HenrikssonHenrik StjernmanMartin RejlerDaniel SjögrenGunnar CedersundWolf BartholomäIngvar RydénPeter LundbergStergios KechagiasOlof Dahlqvist LeinhardMattias EkstedtPublished in: BMC gastroenterology (2023)
gov/ct2/show/NCT05502198 .